Bank of America’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bank of America’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,953	Closed	-$396K	–	7664
2015 Q1	$396K	Sell	3,953 -10,228	-72%	-$681K	﹤0.01%	4477
2014 Q4	$744K	Buy	14,181 +10,889	+331%	+$320K	﹤0.01%	4290
2014 Q3	$85K	Sell	3,292 -695	-17%	-$14.8K	﹤0.01%	6137
2014 Q2	$89K	Buy	+3,987	New	+$87.2K	﹤0.01%	6227

Bank of America's ASPX Position: Q2 2015 in Review

Bank of America sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 3,953 shares — an estimated $396K sold.

Bank of America first reported a position in ASPX in Q2 2014 and held it in 4 quarters. The position peaked at $744K in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Bank of America reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Bank of America sold 3,953 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $396K.
Bank of America first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
Bank of America's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $744K in Q4 2014.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Bank of America's 13F filing for Q2 2015, filed 14 Aug 2015.